pyrazolanthrone has been researched along with Leukopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheunsuchon, B; Chuncharunee, A; Limjindaporn, T; Noisakran, S; Sreekanth, GP; Yenchitsomanus, PT | 1 |
| Atkins, RC; Hurst, L; Ikezumi, Y; Nikolic-Paterson, DJ | 1 |
2 other study(ies) available for pyrazolanthrone and Leukopenia
| Article | Year |
|---|---|
JNK1/2 inhibitor reduces dengue virus-induced liver injury.
Topics: Animals; Anthracenes; Apoptosis; Caspases; Dengue Virus; Disease Models, Animal; Leukopenia; Liver; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Severe Dengue; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Viral Load | 2017 |
Macrophage-mediated renal injury is dependent on signaling via the JNK pathway.
Topics: Animals; Anthracenes; Antibodies; Antineoplastic Agents, Alkylating; Autoantibodies; Blotting, Western; Bone Marrow Cells; Cyclophosphamide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Immunoglobulin G; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Kidney; Leukopenia; Macrophages; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Nitric Oxide; Rats; Sheep; Signal Transduction; Time Factors | 2004 |